2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1 -oate is an innovative biomedical chemical. Utilizing its unique chemical composition, it actively disrupts malignant molecular pathways to prevent tumor proliferation. Its superb targeted delivery capabilities act as a catalyst, amplifying the therapeutic effects and propelling it to the forefront of promising targeted cancer treatment candidates.
Structure of 1232769-29-7
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
2,5-Dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate (abbreviated as PDP) is crucial in the field of drug delivery systems. Its unique chemical structure allows it to form stable conjugates with various drug molecules, enhancing their solubility and bioavailability. This characteristic is especially beneficial for poorly water-soluble drugs, making PDP an invaluable component in formulating new pharmaceutical compounds. It provides a stable and biodegradable linkage that can be cleaved under physiological conditions, releasing the active pharmaceutical ingredient precisely where and when it is needed. Consequently, PDP is likely to play a significant role in the design of next-generation drug delivery systems aimed at improving therapeutic outcomes while minimizing side effects.
In the realm of biomaterials, PDP serves as a cross-linking agent in the synthesis of hydrogels. Hydrogels are widely used in various medical applications such as wound dressings, tissue engineering, and drug delivery matrices. The cross-linking properties of PDP enable the formation of hydrogels with desirable mechanical strength and stability. Moreover, the biodegradability of the cross-linked structure ensures that these hydrogels can be safely absorbed or excreted by the body. This makes PDP an essential component in developing biocompatible and environmentally friendly hydrogels that can be customized for specific medical needs. The potential for creating smart hydrogels that respond to environmental stimuli such as pH and temperature further expands the versatility of PDP-based biomaterials.
PDP is also extensively utilized in peptide synthesis. The compound’s active ester group readily reacts with amine groups, facilitating the formation of peptide bonds. This has made PDP a popular reagent in the laboratory for synthesizing complex peptides and proteins. Its use in solid-phase peptide synthesis (SPPS) allows for the efficient and sequential addition of amino acids, making the process more practical and streamlined. Additionally, the high yield and purity of peptides synthesized using PDP make it an indispensable tool in both research and industrial settings. As the demand for synthetic peptides in pharmaceuticals, diagnostics, and as research tools continues to grow, the importance of PDP in this area cannot be overstated.
Finally, PDP finds applications in the field of organic synthesis, particularly in the modification of polymers. This compound can introduce functional groups onto polymer chains, thereby altering their chemical and physical properties. Such modifications are useful in creating specialty polymers with tailor-made characteristics for specific applications, such as in coatings, adhesives, and biomedical devices. By facilitating the introduction of reactive sites within the polymer backbone, PDP enables the subsequent attachment of other functional molecules, enhancing the material’s functionality and usability. The versatility of PDP in polymer chemistry paves the way for innovative solutions in materials science, contributing to advancements in various industrial sectors.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00428 | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate | 1006592-59-1 | |
BADC-00515 | 2,5-Dioxopyrrolidin-1-yl 2,5,7,10-Tetraoxatridecan-13-Oate | 1053657-02-5 | |
BADC-00486 | 2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate | 107348-47-0 | |
BADC-00520 | 2,5-Dioxopyrrolidin-1-yl 3-(benzyloxy)propanoate | 1134280-63-9 | |
BADC-00521 | 2,5-Dioxopyrrolidin-1-yl 3-((2-Fluorobenzyl)oxy)propanoate | 1134280-64-0 | |
BADC-00522 | 2,5-Dioxopyrrolidin-1-yl 3-((2,4-Difluorobenzyl)oxy)propanoate | 1134280-65-1 | |
BADC-00526 | 2,5-Dioxopyrrolidin-1-yl 4-((2-(1,3-Dioxoisoindolin-2-Yl)ethyl)disulfanyl)butanoate | 1190203-91-8 | |
BADC-00476 | 2,5-dioxopyrrolidin-1-yl 2-(dimethylamino)-4-(pyridin-2-yldisulfanyl)butanoate | 1193111-73-7 | |
BADC-00527 | 2,5-Dioxopyrrolidin-1-yl 3-(4-Methoxyphenoxy)propanoate | 1199815-10-5 | |
BADC-00429 | 2,5-dioxopyrrolidin-1-yl 7,10,13-trioxa-4-azahexadec-1-yn-16-oate | 1214319-94-4 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.